David P. Southwell
Director · ROCKET PHARMACEUTICALS, INC.
IndividualSelling only
- 2025
- Aug 6, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David P. Southwell files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Martin Wilson - $335K in RCKT purchases and sales in the last 12 months
- Gaurav Shah - $286K in RCKT purchases and sales in the last 12 months
- Christopher James Stevens - $128K in RCKT purchases and sales in the last 12 months
- Sarbani Chaudhuri - $84K in RCKT purchases and sales in the last 12 months
- Elisabeth Bjork - $34K in RCKT purchases and sales in the last 12 months
- John Militello - $24K in RCKT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David P. Southwell?
David P. Southwell is a corporate insider, tracked as Director of ROCKET PHARMACEUTICALS, INC. (RCKT). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David P. Southwell submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has David P. Southwell been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($700K) across all tracked filings.
